Successful Initial Market Release of SomnoDent® G2

Share Article

Continuing our commitment toward new product innovation, SomnoMed, Inc. is pleased to announce the success of the initial release of our next generation sleep apnea device, SomnoDent G2, in North America.

Continuing our commitment toward new product innovation, SomnoMed, Inc. is pleased to announce the success of the initial release of our next generation sleep apnea device, SomnoDent G2, in North America.

SomnoDent G2 was initially released to a group of selected clinicians from SomnoMed’s Preferred Dental Network and hundreds patients have benefited from this new product.

“The feedback from patients, physicians and dentists has been overwhelmingly positive,” said Anthony White, Vice President of Marketing for SomnoMed. “We will continue to expand availability by inviting more dentists from our network to participate in clinical training sessions in the coming weeks.”

Some of the benefits of the G2 that were most praised among those who participated in the initial release were increased range of advancement, ease of adjusting the appliance, and the standard metal-free design.

“The SomnoDent G2 offers the option of no metal, smaller coupling which is more comfortable and acceptable to patients” says Dr. Kent Smith, SomnoMed Preferred Dentist. “Dental Sleep Medicine Dentists and Sleep Physicians all work toward the same goal – to get the OSA patient compliant with effective treatment. SomnoDent G2 is the best tool I have found to meet this goal.”

SomnoDent G2 provides patients an easy to use modular titration system, allowing instant and accurate measurement with “click to fit” adjustment. This new sleep apnea device features a coupling mechanism that is 20% smaller, slim-line and more posteriorly located. SomnoDent G2 has an increased advancement range, visible metrics, and controlled lateral movement.

Contact
Anthony White,
Vice President of Marketing
http://www.somnomed.com
T: 888.447.6673
F: 972.377.3404

About SomnoMed
SomnoMed is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent® is the most comfortable and effective design and treatment solution for over 100,000 patients in 22 countries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anthony White
SomnoMed
1(888) 447-6673 104
Email >
Visit website